PALISADE BIO, INC. (PALI) Retained Earnings (Accumulated Deficit) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Palisade Bio, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2010 to 2024.
  • Palisade Bio, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$125 M, a 212% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$125 M -$237 M -212% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $122 M +$12.3 M +11.3% Dec 31, 2023 10-K 2024-03-26
Q3 2023 $119 M +$13.3 M +12.6% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $115 M +$13.7 M +13.5% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $112 M +$12.7 M +12.9% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $109 M +$14.6 M +15.4% Dec 31, 2022 10-K 2023-03-22
Q3 2022 $105 M +$201 M Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $101 M +$205 M Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $98.8 M +$339 M Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $94.6 M +$163 M Dec 31, 2021 10-K 2022-03-17
Q3 2021 -$95.7 M +$138 M +59.1% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 -$104 M +$128 M +55.2% Jun 30, 2021 10-Q 2021-08-23
Q1 2021 -$241 M -$11 M -4.78% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 -$68 M +$154 M +69.4% Dec 31, 2020 10-Q 2021-11-12
Q3 2020 -$234 M -$13.9 M -6.31% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 -$232 M -$13.3 M -6.11% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 -$230 M -$12.8 M -5.91% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 -$222 M -$8.35 M -3.91% Dec 31, 2019 10-K 2021-03-22
Q3 2019 -$220 M -$6.63 M -3.11% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 -$218 M -$6.7 M -3.17% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 -$217 M -$5.89 M -2.79% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 -$214 M -$4.92 M -2.36% Dec 31, 2018 10-K 2020-03-27
Q3 2018 -$213 M -$7.92 M -3.86% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 -$211 M -$6.22 M -3.03% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 -$211 M -$10.2 M -5.11% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 -$209 M -$15.7 M -8.12% Dec 31, 2017 10-K 2019-03-22
Q3 2017 -$205 M -$17.7 M -9.46% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 -$205 M -$22.8 M -12.5% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 -$201 M -$22 M -12.3% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 -$193 M -$21.1 M -12.3% Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$188 M -$20.4 M -12.2% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 -$182 M -$20.9 M -12.9% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 -$179 M -$22.5 M -14.4% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 -$172 M -$20.9 M -13.8% Dec 31, 2015 10-K 2017-03-23
Q3 2015 -$167 M -$21.6 M -14.9% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 -$162 M -$20.5 M -14.5% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 -$156 M -$21.8 M -16.2% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 -$151 M -$22.6 M -17.6% Dec 31, 2014 10-K 2016-03-14
Q3 2014 -$146 M -$20.4 M -16.3% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 -$141 M -$22.7 M -19.1% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 -$134 M -$22.2 M -19.8% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 -$128 M -$19.8 M -18.3% Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$125 M -$19.2 M -18.2% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 -$118 M -$15.1 M -14.7% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 -$112 M -$11.3 M -11.2% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 -$109 M -$10.1 M -10.3% Dec 31, 2012 10-K 2014-03-10
Q3 2012 -$106 M -$9.96 M -10.4% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 -$103 M -$10.6 M -11.4% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 -$101 M Mar 31, 2012 10-Q 2012-05-09
Q4 2011 -$98.5 M -$12.5 M -14.6% Dec 31, 2011 10-K 2013-03-15
Q3 2011 -$95.9 M Sep 30, 2011 10-Q 2011-11-09
Q2 2011 -$92.7 M Jun 30, 2011 10-Q/A 2011-09-23
Q4 2010 -$86 M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.